Bayer AG is no longer planning to sell its diabetes unit, Joerg Reinhardt, Chief Executive Officer of Bayer HealthCare AG, said. Joerg Reinhardt said, "We are keeping it. We evaluated different options and we came to the conclusion that we continue to be the best owner.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.94 EUR | +1.11% |
|
+2.94% | -19.91% |
Jul. 12 | European Midday Briefing : Stocks Extend Rally as U.S. Rate Cut Hopes Deepen | DJ |
Jul. 12 | BAYER AG : Jefferies gives a Neutral rating | ZD |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.91% | 28.86B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer Not To Sell Diabetes Unit